Scientific & Regulatory Consulting•Toxicology & Product Safety
Request basket0
PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Didecyldimethylammonium→

Didecyldimethylammonium PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
20256-56-8
Molecular formula
C22H48N+
Molecular weight
326.6 g/mol
Drug class
Quaternary ammonium cationic surfactantdisinfectant and biocidal active ingredient
Mechanism of action
Disrupts microbial cell membranes by adsorbing to membrane phospholipids and increasing permeability, causing leakage of intracellular contents. It is predominantly used in surface disinfectants and biocidal formulations.
Indications / reported uses
  • Disinfection of environmental surfaces, equipment and selected hard surfaces in authorised biocidal products; not a systemic human therapeutic API indication

Sources: ECHA — Didecyldimethylammonium chloride substance information · PubChem — Didecyldimethylammonium chloride · FDA product information

View request basketPrefer email? [email protected]
PDE / ADE derivationOEL derivationOEB / OHC bandingRequest basket0
Substance information

Drug class, mechanism of action and general use cases

Drug class

Quaternary ammonium cationic surfactant; disinfectant and biocidal active ingredient

Mechanism of action

Disrupts microbial cell membranes by adsorbing to membrane phospholipids and increasing permeability, causing leakage of intracellular contents. It is predominantly used in surface disinfectants and biocidal formulations.

General use cases

  • Disinfection of environmental surfaces, equipment and selected hard surfaces in authorised biocidal products; not a systemic human therapeutic API indication

For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.

Assessment scope

Project-specific PDE/ADE and OEL/OEB support

Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.

  • PDE/ADE: critical effects, point of departure and justified adjustment factors.
  • OEL: inhalation hazards, exposure duration and workplace conditions.
  • OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
  • Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope

PDE/ADE and OEL/OEB assessment

ReguSight provides project-specific support for Didecyldimethylammonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Didecyldimethylammonium Permitted Daily Exposure (PDE) report (the Didecyldimethylammonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Didecyldimethylammonium Occupational Exposure Limit (OEL) report (the Didecyldimethylammonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.